Tag: Prescription Drugs
SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes
Findings show greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors
Cholinesterase Inhibitors Beneficial for Dementia With Lewy Bodies
Use of ChEIs significantly slowed cognitive decline at follow-ups compared with memantine and nonuse
Increasing Thiazide Dose Linked to Greater Reduction in Calcium
Cumulative incidence of symptomatic stone event decreased with increasing calcium change after thiazide prescription
Ubrogepant Administered During Prodrome Beneficial for Migraine
Greater ability to function normally, greater reduction in activity limitations, and greater rate of satisfaction seen with medication
Lecanemab-Labeled Amyloid Plaques Identified in Down Syndrome
Extensive binding of lecanemab to brain blood vessels observed in Down syndrome postmortem brain tissue analysis
Elinzanetant Efficacious, Well-Tolerated for Vasomotor Symptoms
Two phase 3 trials showed that elinzanetant reduced VMS frequency and improved VMS severity at weeks 4 and 12
Olaparib Monotherapy Yields Good PSA Response Rates in Prostate Cancer
Response rates seen in patients with high-risk biochemically recurrent prostate cancer after radical prostatectomy
Two-Thirds of COPD Hospitalized Patients Misuse Inhalers
Most misuse inhalers due to critical error in the inhalation technique
Socially, Economically Disadvantaged Communities Lack Access to Buprenorphine
Findings not seen for communities with racial or ethnic segregation alone
Belzutifan Improves Progression-Free Survival in Advanced Renal Cell Cancer
Belzutifan beneficial for advanced clear cell renal cell carcinoma patients who had previously received immune checkpoint, antiangiogenic therapies
